SCHEMBL3314524

SCHEMBL3314524

COC(=O)C(O)=CC(=O)c1cc(Cl)ccc1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
TP53 P04637 2/20 0.50
CXCL12 P48061 1/20 0.46
MAPT P10636 1/20 0.46
ERCC5 P28715 1/20 0.45
FEN1 P39748 1/20 0.45
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
HPGD P15428 1/20 0.42
CYP2C19 P33261 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
KDM4E B2RXH2 1/20 0.42
HSD17B10 Q99714 1/20 0.42
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
POLB P06746 1/20 0.40
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
LMNA P02545 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3314519 1.00 ALDH1A1 (0.50) ALDH1A1TP53CXCL12MAPTERCC5
SCHEMBL3311846 0.88 ALDH1A1 (0.60) ALDH1A1CXCL12MAPTERCC5FEN1
SCHEMBL3311844 0.88 ALDH1A1 (0.60) ALDH1A1CXCL12MAPTERCC5FEN1
SCHEMBL3316031 0.84 ALDH1A1 (0.44) ALDH1A1MAPTCYP1A2CYP2C19KDM4E
SCHEMBL3316028 0.84 ALDH1A1 (0.44) ALDH1A1MAPTCYP1A2CYP2C19KDM4E
SCHEMBL34470491 0.82 CXCL12 (0.48) ALDH1A1CXCL12MAPTRAB9ASMN1; SMN2
SCHEMBL3311029 0.82 ALDH1A1 (0.58) ALDH1A1TP53CXCL12MAPTERCC5
SCHEMBL3308122 0.82 ALDH1A1 (0.58) ALDH1A1TP53CXCL12MAPTERCC5
SCHEMBL3311027 0.82 ALDH1A1 (0.58) ALDH1A1TP53CXCL12MAPTERCC5
SCHEMBL2235288 0.78 GAA (0.50) ALDH1A1MAPTCYP1A2CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664255-B2 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-03-04 US claimed
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-06-19 US disclosed
US-8664255-B2 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-03-04 US disclosed
US-20100113477-A1 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof TEXAS A&M UNIVERSITY SYSTEM, THE 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113477-A1 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof ME3, ME1, MDH1 ALDH1A1 620/4885TP53 2375/4885CXCL12 4277/4885
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof ME3, ME1, MDH1 ALDH1A1 620/4885TP53 2375/4885CXCL12 4277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.